Ceftriaxone (Rocephin): Uses, MOA, Warnings
Quick summary: Ceftriaxone is a broad-spectrum cephalosporin antibiotic used by injection for several serious bacterial infections. In the United States, the brand name is Rocephin. This article explains common uses, how it works, administration...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary: Ceftriaxone is a broad-spectrum cephalosporin antibiotic used by injection for several serious bacterial infections. In the United States, the brand name is Rocephin.
This article explains common uses, how it works, administration basics, and important safety points to review with the official medication guide or a healthcare professional.
Medical disclaimer: This content is for general information only. It does not replace the advice of a doctor, pharmacist, or the FDA-approved prescribing information. Do not use this page to diagnose an illness or to decide on treatment changes.
What is ceftriaxone?
Ceftriaxone is an active ingredient used in the treatment of several bacterial infections. It is given by intramuscular (IM) or intravenous (IV) injection.
The product ingredient is ceftriaxone sodium. In the United States, a well-known brand name is Rocephin.
How ceftriaxone works
Ceftriaxone is a broad-spectrum, long-acting cephalosporin. Its bactericidal activity comes from inhibiting bacterial cell wall synthesis.
What ceftriaxone is used for
The original content lists ceftriaxone as being used for serious infections caused by microorganisms sensitive to it, including:
- Bacterial meningitis
- Peritonitis and other abdominal infections
- Biliary tract infections
- Osteoarticular infections
- Complicated skin and soft tissue infections
- Complicated urinary tract infections, including pyelonephritis
- Respiratory tract infections
- Genital tract infections, including gonococcal disease
- Stages II and III of Lyme disease
- Bacteremia associated with, or suspected to be associated with, the infections above
It is also listed for prophylaxis of postoperative infections in contaminated or potentially contaminated surgery, especially cardiovascular surgery, urologic procedures, and colorectal surgery.
Administration and dosage information
Important: Dosing must be determined by a qualified clinician and checked against the official product information. The details below reflect the original content only.
| Group | Original content summary |
|---|---|
| Adults, children over 12 years, and children weighing at least 50 kg | 1–2 g every 24 hours; in severe cases or with moderately sensitive bacteria, up to 4 g once daily |
| Uncomplicated gonococcal disease | 250 mg IM as a single dose |
| Stages II and III of Lyme disease | 50 mg/kg per day up to a maximum of 2 g/day for 14 days |
| Perioperative prophylaxis | 1–2 g 30–90 minutes before the intervention, single dose |
| Neonates up to 14 days | 20–50 mg/kg every 24 hours, single dose; maximum 50 mg/kg |
| Neonates 15–28 days, infants 28 days–23 months, and children 2–11 years | 20–80 mg/kg every 24 hours, single dose |
| Bacterial meningitis in children | Start with 100 mg/kg per day, maximum 4 g |
The original content also notes that in severe infections caused by Gram-negative organisms, ceftriaxone may be used with aminoglycosides under clinical supervision.
For severe renal insufficiency, the original content states that dose adjustment may be needed, and for creatinine clearance below 10 mL/min the maximum is 2 g/day.
How it is given
Intravenous use
IV administration should be given for at least 30 minutes.
Intramuscular use
The injection must be reconstituted before use and injected into a relatively large muscle. The original content recommends not injecting more than 1 g in the same place.
Calcium-containing solutions
The original content warns that solutions containing calcium such as Ringer’s solution or Hartmann’s solution should not be used to reconstitute ceftriaxone or to dilute it for IV use, because precipitates may form.
It also states that ceftriaxone and calcium-containing solutions should not be mixed or administered simultaneously in the same IV line.
Contraindications listed in the original content
- Hypersensitivity to ceftriaxone
- Immediate or severe hypersensitivity to penicillins or other beta-lactam antibiotics
- Preterm infants up to the corrected age of 41 weeks
- Term newborns up to 28 days with jaundice, hypoalbuminemia, or acidosis, or when IV calcium treatment or calcium-containing infusions are needed or expected
Warnings and cautions
- Check for a history of hypersensitivity to cephalosporins and penicillins before treatment.
- Watch for hypersensitivity reactions, pseudomembranous colitis, superinfection by resistant microorganisms, and pancreatitis.
- High doses and treatment longer than 14 days require caution.
- Dehydration or renal failure may be associated with ceftriaxone-calcium precipitates in the gallbladder, which may look like biliary stones on ultrasound.
- Blood counts should be monitored during prolonged treatment.
- Severe renal insufficiency may require dose adjustment.
- Fatal reactions have been described in premature and term newborns under 1 month due to calcium-ceftriaxone precipitates in the lungs and kidneys.
- Serious skin reactions have been reported, including DRESS, and Jarisch-Herxheimer reaction may occur in spirochete infections.
Kidney failure
The original content advises caution in severe renal failure and notes a maximum of 2 g/day when creatinine clearance is below 10 mL/min.
Interactions and laboratory test effects
- Not recommended with bacteriostatic antibiotics, especially in acute infections.
- May antagonize chloramphenicol.
- Probenecid at high doses may inhibit excretion.
- May reduce the effectiveness of hormonal contraceptives; additional measures were noted in the original content during treatment and for the following month.
- May cause false-positive results in the Coombs test and galactosemia test.
- May affect urine glucose testing with non-enzymatic methods.
Pregnancy and breastfeeding
The original content says the risk-benefit balance should be assessed in pregnancy and that clinical data in exposed pregnant women were not available in that source. It also notes no experimental evidence of embryopathic or teratogenic effects in animals.
For breastfeeding, the original content states that ceftriaxone is excreted in breast milk and should be used with caution.
Effects on driving and using machines
The original content says the effect on driving and machine use is negligible, although occasional dizziness may occur.
Adverse reactions listed in the original content
Reported adverse reactions include diarrhea, nausea, stomatitis, and glossitis.
Safety reminder
If you have been prescribed ceftriaxone, confirm the exact dose, route, and duration with the official leaflet or your healthcare professional. Seek urgent medical help for signs of severe allergy, breathing problems, or serious skin reactions.
Frequently asked questions
▸ Is ceftriaxone the same as Rocephin?
Rocephin is the brand name mentioned in the original content for ceftriaxone in the United States.
▸ What type of antibiotic is ceftriaxone?
It is a broad-spectrum cephalosporin antibiotic used by injection.
▸ Can ceftriaxone be mixed with calcium-containing fluids?
The original content says it should not be mixed with calcium-containing solutions or administered simultaneously in the same IV line.
▸ What should be checked before treatment?
The original content highlights allergy history, kidney function in severe cases, and special caution in newborns.
▸ Does ceftriaxone affect lab tests?
Yes. The original content notes possible false-positive results in the Coombs test and galactosemia test, and interference with some urine glucose methods.
Source note: This page was rewritten from the original content and should be checked against the FDA-approved medication guide and prescribing information for the specific product.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.